| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8557 |
| Human Intestinal Absorption | HIA+ | 0.9816 |
| Caco-2 Permeability | Caco2+ | 0.6887 |
| P-glycoprotein Substrate | Non-substrate | 0.7235 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8575 |
| Non-inhibitor | 0.9401 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8826 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9357 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8190 |
| CYP450 2D6 Substrate | Non-substrate | 0.9047 |
| CYP450 3A4 Substrate | Non-substrate | 0.6519 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9183 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9339 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9594 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9812 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9559 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8594 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9632 |
| Non-inhibitor | 0.9239 |
| AMES Toxicity | Non AMES toxic | 0.9650 |
| Carcinogens | Non-carcinogens | 0.8398 |
| Fish Toxicity | High FHMT | 0.8980 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9987 |
| Honey Bee Toxicity | High HBT | 0.6451 |
| Biodegradation | Not ready biodegradable | 0.6648 |
| Acute Oral Toxicity | II | 0.7505 |
| Carcinogenicity (Three-class) | Non-required | 0.6930 |